The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine
Abstract
Data were analyzed from a multicenter observational cohort study of 1002 persons with AIDS or AIDS-related complex (ARC) and total CD4 cell count < 0.25 x 10(9)/L treated with zidovudine between April 1987 and April 1988. Cytomegalovirus (CMV) disease developed in 109 patients (10.9%), with a 2-year actuarial risk of 15%. Manifestations included retinitis (93 patients), esophagitis (10), colitis (8), gastritis (1), hepatitis (1), and encephalitis (1). The probability of CMV disease at 2 years for patients with initial counts < 0.1 x 10(9)/L was 21.4%, compared with 10.3% for patients with initial counts > or = 0.1 x 10(9)/L (P < .001). By proportional hazards analysis, baseline CD4 cell count < 0.1 x 10(9)/L, enrollment diagnosis of AIDS, and homosexuality were significantly associated with subsequently developing CMV disease. Median survival after diagnosis of CMV disease was 173 days, and CMV was an independent predictor of death. CMV contributes to AIDS-related morbidity and mortality. As new anti-CMV drugs become available, prophylaxis should be targeted at individuals with CD4 cell counts < 0.1 x 10(9)/L.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Self-citationAutopsy pathology in the acquired immune deficiency syndrome.
Reichert, C. M., O’Leary, T. J., Levens, D., Simrell, C. R., & Macher, A. M. (1983) · PubMed · Cited by 528
(1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260401 · Cited by 487
Prevalence of Cytomegalovirus Infection in Homosexual Men
Drew, W. L., Mintz, L., Miner, R. C., Sands, M., & Ketterer, B. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.2.188 · Cited by 437
Fischl, M. A. (1988) · JAMA · doi:10.1001/jama.259.8.1185 · Cited by 422
Herpesvirus Infections in the Acquired Immune Deficiency Syndrome
Quinnan, G. V. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350010038020 · Cited by 398
A note on the product-limit estimator under right censoring and left truncation
TSAI, W.-Y., JEWELL, N. P., & WANG, M.-C. (1987) · Biometrika · doi:10.1093/biomet/74.4.883 · Cited by 353
Leoung, G. S., Feioal, D. W., Montgomery, A. B., Corkery, K., Wardlaw, L., Adams, M., Busch, D., Gordon, S., Jacobson, M. A., Volberding, P. A., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231201 · Cited by 299
Zidovudine and the Natural History of the Acquired Immunodeficiency Syndrome
Moore, R. D., Hidalgo, J., Sugland, B. W., & Chaisson, R. E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242006 · Cited by 278
Self-citationSerologic and Immunologic Studies in Patients With AIDS in North America and Africa
Quinn, T. C. (1987) · JAMA · doi:10.1001/jama.1987.03390190095027 · Cited by 230
The Effects on Survival of Early Treatment of Human Immunodeficiency Virus Infection
Graham, N. M. H., Zeger, S. L., Park, L. P., Vermund, S. H., Detels, R., Rinaldo, C. R., & Phair, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204163261601 · Cited by 212
Survival Experience Among Patients With AIDS Receiving Zidovudine
Creagh-Kirk, T. (1988) · JAMA · doi:10.1001/jama.1988.03410200065027 · Cited by 171
Chaisson, R. E., Moore, R. D., Richman, D. D., Keruly, J., Creagh, T., & The Zidovudine Epidemiology Study Group (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.285 · Cited by 163
Self-citationLatent Infection and the Elusive Cytomegalovirus
Jordan, M. C. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.2.205 · Cited by 158
VALUE OF NECROPSY IN ACQUIRED IMMUNODEFICIENCY SYNDROME
Wilkes, M., Felix, J., Fortin, A., Godwin, T., & Thompson, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90014-1 · Cited by 158
Cytomegalovirus infection in homosexual men
Collier, A. C., Meyers, J. D., Corey, L., Murphy, V. L., Roberts, P. L., & Handsfield, H. H. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90105-7 · Cited by 108
Cited by
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., & Robinson, C. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401402 · Cited by 485
A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
Martin, D. F., Sierra-Madero, J., Walmsley, S., Wolitz, R. A., Macey, K., Georgiou, P., Robinson, C. A., & Stempien, M. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011759 · Cited by 394
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
Jacobson, M. A., Zegans, M., Pavan, P. R., O'Donnell, J. J., Sattler, F., Rao, N., Owens, S., & Pollard, R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11431-8 · Cited by 366
Metadata
- Authors
- Gallant, J. E., Moore, R. D., Richman, D. D., Keruly, J., Chaisson, R. E., & Zidovudine Epidemiology Study Group
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-12-01
- Volume
- 166
- Issue
- 6
- Pages
- 1223-1227
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1967840486
- Cited by
- 529
- References
- 16
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.